These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33448560)

  • 1. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
    Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
    Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
    Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
    Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis in adult lung transplant recipients: Uncertainty despite 30 years of experience. A systematic review of the literature and network meta-analysis.
    Marinelli T; Davoudi S; Foroutan F; Orchanian-Cheff A; Husain S
    Transpl Infect Dis; 2022 Jun; 24(3):e13832. PubMed ID: 35388588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
    Cadena J; Levine DJ; Angel LF; Maxwell PR; Brady R; Sanchez JF; Michalek JE; Levine SM; Restrepo MI
    Am J Transplant; 2009 Sep; 9(9):2085-91. PubMed ID: 19645709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
    Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
    Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
    Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of antifungal prophylaxis in preventing invasive
    Carugati M; Arif S; Yarrington ME; King LY; Harris M; Evans K; Barbas AS; Sudan DL; Perfect JR; Miller RA; Alexander BD
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0127923. PubMed ID: 38299818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.
    Herity LB; Cruz OA; Aziz MT
    J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods.
    López-Medrano F; Muñoz de la Espada M; Pérez-Jacoiste Asín MA; Fernández-Ruiz M; Herrero-Martínez JM; Alonso-Carrillo J; San Juan R; Rodríguez-Goncer I; Andrés A; González E; Manrique A; Justo I; Marcacuzco A; Loinaz C; Jiménez C; Lumbreras C; Aguado JM
    Mycoses; 2022 May; 65(5):517-525. PubMed ID: 35262977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.
    Jorgenson MR; Descourouez JL; Marka NA; Leverson GE; Smith JA; Andes DR; Fernandez LA; Foley DP
    Transpl Infect Dis; 2019 Oct; 21(5):e13156. PubMed ID: 31390109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
    J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single-center experience.
    Lavezzo B; Patrono D; Tandoi F; Martini S; Fop F; Ballerini V; Stratta C; Skurzak S; Lupo F; Strignano P; Donadio PP; Salizzoni M; Romagnoli R; De Rosa FG
    Transpl Infect Dis; 2018 Apr; 20(2):e12859. PubMed ID: 29427394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.